MENU
INAB
Stock ticker:
PRICE
CHANGE
CAPITALIZATION
IN8bio (INAB) Ownership - Who owns IN8bio?
Profile
Industry
N/A
Address
350 5th Avenue
Phone
+1 646 600-6438
Employees
31
Web
https://www.in8bio.com
Details
Group
Domestic Stock Funds
Category
Biotechnology
Capitalization
12.63M
P/E Ratio
N/A
Total Cash
10.22M
Projected Growth
N/A
Total Debt
5.9M
Revenue
N/A
Risk (Beta)
0.11
Dividend Yield
N/A
Total Cash/Share
0.22
Total Debt/Equity
N/A
Revenue/Share
null USD as % of share price
Fundamentals
INAB
Capitalization
12.6M
P/E Ratio
N/A
Risk (Beta)
0.11
Dividend Yield
N/A
Total Cash
10.2M
Total Cash/Share
0.22
Total Debt
5.9M
Total Debt/Equity
N/A
Projected Growth (PEG Ratio)
N/A
Revenue/Share (as % of the share price)
0%
Revenue
0
ROE
N/A
Book Value
13.6M
P/B Ratio
0.93
Cash Flow
N/A
Earnings
-0.82
Average Daily Volume YTD
N/A
Common Shares Outstanding - Security Level
5K
Current Ratio
2.66
Current Revenue Per Employee
N/A
Dividends Per Share - Security
N/A
EBITDA
-29.89M
Float
N/A
Float - Current
N/A
Gross Income Margin
N/A
Revenue To Assets
-122.41
Shares Held By Institutions
8.54M
Shares Outstanding - Current
46.8M
Total Liabilities
8.88M
Total Volume MTD
N/A
Value
1
Gain YTD
-83.413
View a ticker or compare two or three
VS
VS
Show more...
Ad is loading...
A.I.Advisor
published price charts
A.I. Advisor
published General Information
General Information
Industry Biotechnology
Profile
Fundamentals
Details
Industry
N/A
Address
350 5th Avenue
Phone
+1 646 600-6438
Employees
31
Web
https://www.in8bio.com